News
Our CEO, Zandy Forbes, spoke with Moira Gunn on @NPR's @biotechnation podcast about our approach to #GeneTherapy. To learn about everything from our #Phase3 program in #RPGR to our riboswitch #GeneRegulation platform, listen to the interview here: https://t.co/5aPcFLGUBd pic.twitter.com/tnAklYOzcP
— MeiraGTx (@MeiraGTx) November 23, 2022
